With Q4 Data In, Biopharma VC Fundraising Reached Highest Total Since 2021
Fourth Quarter Continued Trend Of Uptick From 2023
Evaluate data from the fourth quarter of 2024 show another period of venture capital fundraising that beat each quarter of 2023, as $100m-plus mega-rounds surged.
